Loading...
Recombinant human erythropoietin improves neurological outcomes in very preterm infants
OBJECTIVE: To evaluate the efficacy and safety of repeated low‐dose human recombinant erythropoietin (rhEPO) in the improvement of neurological outcomes in very preterm infants. METHODS: A total of 800 infants of ≤32‐week gestational age who had been in an intensive care unit within 72 hours after b...
Na minha lista:
Udgivet i: | Ann Neurol |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
John Wiley and Sons Inc.
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084793/ https://ncbi.nlm.nih.gov/pubmed/27130143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.24677 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|